Press release
Rectal Cancer Therapeutics 2018 - Key Players Analysis Sanofi, Advaxis, Inc., TLC Biopharmaceuticals
*Rectal Cancer Therapeutics Pipeline in 2018
Rectal cancer is a disease in which malignant (cancer) cells are formed in the tissues of the rectum. The rectum is the lower part of the colon that connects the large bowel to the anus. It starts at the end of the final segment of the colon and ends when it reaches the short, narrow passage leading to the anus. Adenocarcinomas or cancer in the epithelium, comprise the vast majority of colon and rectal cancers; some of the rare rectal cancers include lymphoma, carcinoid and sarcoma. It has been observed that, there are no early symptoms of rectal cancer, but some of the generalized symptoms include, pain in rectum, change in appetite, fatigue or tiredness, unintended weight loss and stomach cramps.
Browse report sample at: https://www.psmarketresearch.com/market-analysis/rectal-cancer-therapeutics-pipeline-analysis/report-sample
*Rectal Cancer Therapeutics Pipeline is Witnessing Significant Growth due to Growing Need for Targeted Therapies
It has been observed that most of the therapeutics that are being developed for acting on the specific target, and interventional studies including targeted therapeutics for the treatment of rectal cancer, have showed positive efficacy in the clinical as well as Pre-Clinical stage of development. An example of such therapy includes, Ziv-aflibercept, a fusion protein, under the Phase II stage of development by Sanofi S.A. for the treatment of rectal cancer. Ziv-aflibercept has been approved by USFDA for use in combination with 5-fluorouracil, leucovorin, and irinotecan in patients with metastatic colorectal cancer and rectal cancer.
Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=rectal-cancer-therapeutics-pipeline-analysis
*Growing Geriatric Population to Immensely Support Rectal Cancer Therapeutics Pipeline Growth
It has been observed that, rise in geriatric population and increasing incidence of rectal cancer has been driving the growth of the rectal cancer pipeline. Colorectal cancer includes both colon and rectal cancers. According to the National Cancer Institute, in 2017, the incident cases of colorectal cancer were found as 40.1 per 100,000 people per year. The increasing geriatric population is mostly frail and unable to tolerate the treatments such as radiation therapy and chemotherapy for the treatment of cancer. This is one of the most prominent factor due to which companies are focusing towards development of therapeutics for the treatment of rectal cancer.
Browse report at: https://www.psmarketresearch.com/market-analysis/rectal-cancer-therapeutics-pipeline-analysis
Some of the key players involved in the development of rectal cancer therapeutics include Taiwan Liposome Company, Sanofi and Advaxis Inc.
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rectal Cancer Therapeutics 2018 - Key Players Analysis Sanofi, Advaxis, Inc., TLC Biopharmaceuticals here
News-ID: 1439772 • Views: …
More Releases from P&S Intelligence
Remote Access Provided by Cloud Category Fuels Call Center AI Market
In 2021, the call center AI market generated sales worth $1,982.9 million, and it is expected to contribute $12,910.6 million in 2030, progressing at a rate of 23.1% from 2021 to 2030, ascribed to the growing up requirements for improved data analytics to manage customer inquiries with the real-time response to improve customer engagement through social media.
In order to pace up the 4th industrial revolution, businesses across various industries…
Growing Demand for CSM System Will Drive the Customer Engagement Solutions Marke …
The total value of the customer engagement solutions market was $18,186.8 million in 2021, and it will rise at a growth rate of above 10% in the near future, to reach $43,398.9 million by 2030. The major reasons behind the growth of this industry are growing usage of such solutions in serval industries like healthcare, telecommunications, BFSI and FMCG.
North America will grow the fastest with a rate of 10.5% in…
Reduced Operational Cost of Energy Efficient Motors Propels Motion Control Marke …
The motion control market generated a revenue of $14,887.5 million in 2021, and it is expected to contribute $23,286.4 million in 2030, progressing at a rate of 5.1% from 2021 to 2030, ascribed to the rising demand for industrial robots and integration of components with the motion control systems for convenient use.
Moreover, the evolving motion control standards and protocols propel the market, for example, the OPC UA TSN protocol controls…
North America, the Largest Revenue Producer in Public Safety and Security Market
The size of the public safety and security market was at $411 billion in the year 2021, which will reach over $1,115 billion by the year 2030, advancing at a growth rate of around 12% in the years to come. This is largely ascribed to the rising application of innovative technologies in smart cities, increasing crime rates, the increasing cases of disastrous accidents, and the growing count of terrorist activities…
More Releases for Rectal
2022-2028 Rectal Irrigation Market | Detailed Report
Global Rectal Irrigation Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5352935
The report provides a…
Rectal Probe Market Demand by 2025: QY Research
Global Rectal Probe Market report is designed in a method that helps readers to acquire a complete knowledge about the overall market scenario for the projected period. This Market report consists of the brief profile of key players in the industry and their upcoming market plans and current developments during the forecasted period 2018 to 2025.
The report of global Rectal Probe market includes the competitive landscape section which provides…
Rectal Cancer - Pipeline Review, H1 2018 by MarketResearchReports.biz
"The Report Rectal Cancer - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
About Rectal Cancer Market
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rectal Cancer - Pipeline Review, H1 2018, provides an overview of the Rectal Cancer (Oncology) pipeline landscape.
Rectal cancer affects the lower part of the colon, which connects the large…
Rectal Cancer - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Rectal Cancer - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rectal Cancer - Pipeline Review, H2 2017, provides an overview of the Rectal Cancer (Oncology) pipeline landscape.
Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The risk…
Rectal Cancer-Pipeline Review H2 2017
ReportsWeb.com has announced the addition of the “Rectal Cancer-Pipeline Review H2 2017” this report provides an overview of the Rectal Cancer (Oncology) pipeline landscape.
Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The risk factors for developing rectal cancer are increasing age, smoking, family history of colon or rectal cancer, high-fat diet and/or a diet mostly from animal sources and personal or…
Rectal Cancer Market Is Expected To Profits by 2016 - 2024
Rectal cancer is a malignant disease in which cancer cells form in the tissues of the rectum. The digestive system takes in nutrients from foods consumed by the host and helps waste material pass out of the body through the anus. There are various causes that contribute to the occurrence of rectal cancer such as increasing age (mostly over 50), having certain family history of rectal cancer, history of polyps or colorectal…
